News
BDPT
0.0020
+25.00%
0.0004
Weekly Report: what happened at BDPT last week (0914-0918)?
Weekly Report · 16h ago
Weekly Report: what happened at BDPT last week (0907-0911)?
Weekly Report · 09/14 09:53
Weekly Report: what happened at BDPT last week (0831-0904)?
Weekly Report · 09/07 09:49
BioAdaptives Confirms First Commercial Orders of XcellaraHeart(TM) and Outlines Capital Restructuring Progress
Barchart · 09/03 10:15
Weekly Report: what happened at BDPT last week (0824-0828)?
Weekly Report · 08/31 09:54
UFC Hall of Famer Michael Bisping Joins BioAdaptives to Champion MyndSystem(TM)
Barchart · 08/31 04:30
Weekly Report: what happened at BDPT last week (0817-0821)?
Weekly Report · 08/24 09:54
Weekly Report: what happened at BDPT last week (0810-0814)?
Weekly Report · 08/17 09:55
BioAdaptives, Inc. Announces CEO's Share Cancellation and Provides Capital Restructure Update
Barchart · 08/13 07:35
Weekly Report: what happened at BDPT last week (0803-0807)?
Weekly Report · 08/10 09:51
BioAdaptives Explains the Scientific Basis of the Dual-Action Xcellara(TM) "Supply and Direction" Platform
Barchart · 08/04 07:00
Weekly Report: what happened at BDPT last week (0727-0731)?
Weekly Report · 08/03 09:51
BioAdaptives Inc. Eliminates Major Market Overhang by Retiring the Debt of the Largest Convertible Commercial Investor
Barchart · 07/30 07:30
BioAdaptives Inc. Reports Scaling of E-Commerce Footprint and Consumer Reach for MyndSystem(TM) Nootropic Platform
Barchart · 07/29 12:15
Weekly Report: what happened at BDPT last week (0720-0724)?
Weekly Report · 07/27 09:54
Weekly Report: what happened at BDPT last week (0713-0717)?
Weekly Report · 07/20 09:51
BioAdaptives® Outlines Xcellara™ Platform Strategy: Integrating Stem Cell Supply and Direction for Targeted Wellness
Barchart · 07/16 07:30
Weekly Report: what happened at BDPT last week (0706-0710)?
Weekly Report · 07/13 09:53
Weekly Report: what happened at BDPT last week (0629-0703)?
Weekly Report · 07/06 09:55
Weekly Report: what happened at BDPT last week (0622-0626)?
Weekly Report · 06/29 09:52
More
Webull provides a variety of real-time BDPT stock news. You can receive the latest news about Bioadaptives through multiple platforms. This information may help you make smarter investment decisions.
About BDPT
BioAdaptives, Inc. operates in the health and wellness industry. The Company’s core business is to investigate, market and distribute natural plant, fungi, and algal based products and medical devices that improve health and wellness for humans and animals, with an emphasis on pain relief, anti-viral function, and anti-aging properties. Its products in development include a weight management supplement in a human clinical trial, Zeranovia. Zeranovia is made of natural ingredients and uses proprietary methods of optimizing the availability of nutrients in foods and beverages. Xcellara regenerative stem cell activator is in production. Xcellara is its regenerative wellness solution, to enhance performance, accelerate recovery, and revitalize health. PawPa Regen is the canine treat stem cell activator. PawPa Regen supports anti-aging and wellness. Its other products include MyndMed and Wynovia. MyndMed is designed to optimize multiple neurotransmitter systems and neuroprotective pathways.